Deborah Dunsire after three years at Lundbeck: "We're coming up to an inflection point in neuroscience"
![Photo: Gregers Tycho/ERH](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13362274.ece/ALTERNATES/schema-16_9/doc7hxnvtc9f5c1gxw4cd7t.jpg)
In many ways, it was a journey back in time for Deborah Dunsire when she took the job as CEO at Lundbeck. This is not to say Denmark's life sciences industry is lagging behind the US. Rather, it has something to do specifically with the disease area with which she is now working.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Lundbeck chairman demands change: "We can't live with this"
For subscribers
New Lundbeck candidate to kick off R&D division
For subscribers